This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: C4 Therapeutics, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Innovations of Jia Li in Targeted Degradation
Introduction
Jia Li is an accomplished inventor based in Watertown, MA (US). He has made significant contributions to the field of targeted degradation, particularly in relation to the BRD9 protein. His work is crucial for developing treatments for disorders mediated by BRD9, including abnormal cellular proliferation.
Latest Patents
Jia Li holds a patent for "Selected compounds for targeted degradation of BRD9." This patent includes selected BRD9 protein degradation compounds and their morphic forms, which are essential for addressing various medical conditions.
Career Highlights
Jia Li is currently employed at C4 Therapeutics, Inc., where he continues to innovate in the field of targeted therapies. His expertise and research are pivotal in advancing the understanding and treatment of diseases linked to BRD9.
Collaborations
Jia Li collaborates with notable colleagues, including Katrina L. Jackson and Christopher G. Nasveschuk. Their combined efforts contribute to the ongoing research and development in their field.
Conclusion
Jia Li's work exemplifies the importance of innovation in medical research, particularly in the targeted degradation of proteins like BRD9. His contributions are paving the way for new therapeutic approaches to complex disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile